Characteristic | Total | |
Gender, n (%) | ||
Male | 172 | (56) |
Female | 133 | (44) |
Race/ethnicity, n (%) | ||
Asian | 42 | (14) |
Black | 15 | (5) |
Hispanic | 11 | (4) |
White | 221 | (72) |
Other | 16 | (5) |
Age category, n (%) | ||
25–34 years | 34 | (11) |
35–44 years | 118 | (39) |
45–54 years | 84 | (28) |
≥55 years | 69 | (23) |
Region, n (%) | ||
East | 94 | (31) |
Midwest | 50 | (16) |
South | 94 | (31) |
West | 67 | (22) |
Medical practice setting, n (%) | ||
Single specialty | 131 | (43) |
Multispecialty or group practice | 163 | (53) |
Other | 11 | (4) |
Years in practice | ||
3 to <10 | 121 | (40) |
10 to <15 | 50 | (16) |
15 to <20 | 47 | (15) |
≥20 | 87 | (29) |
Number of physicians in practice, n (%) | ||
≤25 | 154 | (50) |
26–99 | 78 | (26) |
≥100 | 73 | (24) |
Area of practice, n (%) | ||
Rural | 109 | (36) |
Urban | 141 | (46) |
Suburban | 55 | (18) |
Main insurance type, n (%) | ||
Medicaid | 55 | (18) |
Medicare | 67 | (22) |
Commercial | 164 | (54) |
Unknown | 19 | (6) |
Preferred screening method for pre-diabetes/diabetes, n (%) | ||
HbA1c test | 182 | (60) |
Fasting plasma glucose test | 108 | (35) |
Random plasma glucose test | 9 | (3) |
Oral glucose tolerance test | 5 | (2) |
Other (HbA1C and fasting blood glucose) | 1 | (0) |
Factors that influence decision to screen for diabetes, n (%) | ||
Personal clinical experience | 239 | (78) |
Prompts from electronic medical record system | 51 | (17) |
Screening guidelines | 233 | (76) |
Other | 24 | (8) |
Physician preference for screening guidelines, n (%) | ||
USPSTF | 148 | (64) |
ADA | 166 | (71) |
USPSTF and ADA | 89 | (38) |
USPSTF only | 59 | (25) |
ADA only | 77 | (33) |
Other | 4 | (2) |
None | 3 | (1) |
Physician’s use of screening guidelines*, n (%) | ||
100% of the time | 61 | (26) |
≥70% of the time | 124 | (53) |
≥50% of the time | 39 | (17) |
<50% of the time | 9 | (4) |
USPSTF, n (%) | ||
100% of the time | 23 | (16) |
≥70% of the time | 96 | (65) |
≥50% of the time | 25 | (17) |
<50% of the time | 4 | (3) |
ADA, n (%) | ||
100% of the time | 32 | (19) |
≥70% of the time | 108 | (65) |
≥50% of the time | 22 | (13) |
<50% of the time | 4 | (2) |
*Questions asked to only those physicians who reported screening guidelines influence their decision to screen (n=233). Percentages reported out of total 233 physicians.
ADA, American Diabetes Association; PCP, primary case physician; USPSTF, US Preventive Services Task Force.